Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5655001 | Clinical Immunology | 2016 | 15 Pages |
Abstract
This review details the development, clinical application, and future perspectives of anti-CD20-antibody treatment of NHL, thereby proving the efficiency of immunotherapy via targeting of a tumor associated antigen.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marianne Engelhard,